HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ping-Hui Tseng Selected Research

Sepsis (Septicemia)

7/2014A novel TLR2-triggered signalling crosstalk synergistically intensifies TNF-mediated IL-6 induction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ping-Hui Tseng Research Topics

Disease

9Neoplasms (Cancer)
10/2020 - 02/2004
6Prostatic Neoplasms (Prostate Cancer)
11/2005 - 04/2002
3Inflammation (Inflammations)
07/2015 - 01/2010
3Hepatocellular Carcinoma (Hepatoma)
02/2015 - 07/2014
2Lymphoma (Lymphomas)
07/2014 - 11/2010
2Necrosis
07/2014 - 06/2011
2Ischemia
04/2006 - 04/2002
2Stroke (Strokes)
04/2006 - 04/2002
2Carcinogenesis
11/2005 - 06/2004
1Lung Neoplasms (Lung Cancer)
01/2021
1Pneumonia (Pneumonitis)
01/2017
1Tuberculosis (Tuberculoses)
01/2017
1Porcine Reproductive and Respiratory Syndrome (PRRS)
01/2017
1Liver Neoplasms (Liver Cancer)
07/2014
1Carcinoma (Carcinomatosis)
07/2014
1Leukemia
07/2014
1Sepsis (Septicemia)
07/2014
1B-Cell Leukemia (Leukemia, B Cell)
11/2010
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2010
1Autoimmune Diseases (Autoimmune Disease)
01/2010
1Anthrax
06/2008
1Breast Neoplasms (Breast Cancer)
11/2006
1Vascular Diseases (Vascular Disease)
04/2006
1Brain Ischemia (Cerebral Ischemia)
04/2006
1Glioblastoma (Glioblastoma Multiforme)
11/2005
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2005
1Retinoblastoma (Glioblastoma, Retinal)
12/2004
1Infarction (Infarctions)
04/2002
1Cerebral Infarction
04/2002

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
01/2017 - 04/2002
5Celecoxib (Celebrex)FDA Link
11/2006 - 04/2002
3obatoclaxIBA
02/2015 - 07/2014
3Toll-Like Receptors (Toll-Like Receptor)IBA
07/2014 - 01/2010
3Phosphotransferases (Kinase)IBA
05/2005 - 06/2004
2SC-2001IBA
07/2014 - 07/2014
2CytokinesIBA
07/2014 - 01/2010
2Phosphatidylinositols (Phosphatidylinositol)IBA
11/2006 - 07/2003
2Epoprostenol (Prostacyclin)FDA LinkGeneric
04/2006 - 04/2002
2prostacyclin synthetase (prostacyclin synthase)IBA
04/2006 - 04/2002
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2021
1MicroRNAs (MicroRNA)IBA
10/2020
1C-Type Lectins (C-Type Lectin)IBA
01/2017
1Pattern Recognition ReceptorsIBA
01/2017
1Toll-Like Receptor 4IBA
07/2015
1CopperIBA
02/2015
1PyrrolesIBA
02/2015
1indoleIBA
02/2015
1ProdigiosinIBA
02/2015
1Transcription Factors (Transcription Factor)IBA
12/2014
1Biological ProductsIBA
12/2014
1Sorafenib (BAY 43-9006)FDA Link
07/2014
1Tumor Necrosis Factor Receptor-Associated Peptides and ProteinsIBA
06/2011
1AntigensIBA
11/2010
1B-Cell Activating FactorIBA
11/2010
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
01/2010
1Interferon Type IIBA
01/2010
1Acetylmuramyl-Alanyl-IsoglutamineIBA
06/2008
1Trastuzumab (Herceptin)FDA Link
11/2006
1IGF Type 1 Receptor (IGF 1 Receptor)IBA
11/2006
1OSU 03012IBA
11/2006
1Messenger RNA (mRNA)IBA
04/2006
1Vasodilator Agents (Vasodilators)IBA
04/2006
1Antineoplastic Agents (Antineoplastics)IBA
11/2005
1Histone Deacetylases (Histone Deacetylase)IBA
11/2005
1Histones (Histone)IBA
11/2005
1Protein Phosphatase 1IBA
11/2005
1Histone Deacetylase InhibitorsIBA
11/2005
1Tyrosine (L-Tyrosine)FDA Link
05/2005
1Imatinib Mesylate (Gleevec)FDA Link
05/2005
1Cyclin-Dependent Kinases (cdk Proteins)IBA
12/2004
13-Phosphoinositide-Dependent Protein KinasesIBA
02/2004
1Serum-Free Culture MediaIBA
07/2003
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
07/2003
1Cyclooxygenase 1IBA
04/2002
1EicosanoidsIBA
04/2002
1LeukotrienesIBA
04/2002
1ProstaglandinsIBA
04/2002
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
04/2002
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
04/2002
1AndrogensIBA
04/2002

Therapy/Procedure

2Therapeutics
12/2014 - 06/2004